304 related articles for article (PubMed ID: 27666480)
1. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
[TBL] [Abstract][Full Text] [Related]
2. The role of Galectin-3 in α-synuclein-induced microglial activation.
Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
[TBL] [Abstract][Full Text] [Related]
3. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder.
Park HJ; Oh SH; Kim HN; Jung YJ; Lee PH
Acta Neuropathol; 2016 Nov; 132(5):685-701. PubMed ID: 27497943
[TBL] [Abstract][Full Text] [Related]
5. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia.
Dorion MF; Yaqubi M; Senkevich K; Kieran NW; MacDonald A; Chen CXQ; Luo W; Wallis A; Shlaifer I; Hall JA; Dudley RWR; Glass IA; ; Stratton JA; Fon EA; Bartels T; Antel JP; Gan-Or Z; Durcan TM; Healy LM
Brain; 2024 Feb; 147(2):427-443. PubMed ID: 37671615
[TBL] [Abstract][Full Text] [Related]
6. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein.
Li N; Stewart T; Sheng L; Shi M; Cilento EM; Wu Y; Hong JS; Zhang J
J Neuroinflammation; 2020 Sep; 17(1):272. PubMed ID: 32943057
[TBL] [Abstract][Full Text] [Related]
8. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.
Rojanathammanee L; Murphy EJ; Combs CK
J Neuroinflammation; 2011 May; 8():44. PubMed ID: 21554732
[TBL] [Abstract][Full Text] [Related]
9. Propagation of pathological α-synuclein in marmoset brain.
Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
[TBL] [Abstract][Full Text] [Related]
10. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
11. Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells.
Sarkar S; Dammer EB; Malovic E; Olsen AL; Raza SA; Gao T; Xiao H; Oliver DL; Duong D; Joers V; Seyfried N; Huang M; Kukar T; Tansey MG; Kanthasamy AG; Rangaraju S
Front Immunol; 2020; 11():33. PubMed ID: 32082315
[TBL] [Abstract][Full Text] [Related]
12. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
13. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
[TBL] [Abstract][Full Text] [Related]
15. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates.
Valdinocci D; Grant GD; Dickson TC; Pountney DL
Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation.
Wang S; Chu CH; Stewart T; Ginghina C; Wang Y; Nie H; Guo M; Wilson B; Hong JS; Zhang J
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1926-35. PubMed ID: 25825709
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates.
Acuña L; Hamadat S; Corbalán NS; González-Lizárraga F; Dos-Santos-Pereira M; Rocca J; Díaz JS; Del-Bel E; Papy-García D; Chehín RN; Michel PP; Raisman-Vozari R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349736
[No Abstract] [Full Text] [Related]
18. α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity.
Hu Z; Wang W; Ling J; Jiang C
Cell Mol Neurobiol; 2016 Jul; 36(5):811-20. PubMed ID: 27002719
[TBL] [Abstract][Full Text] [Related]
19. Microglia in dementia with Lewy bodies.
Streit WJ; Xue QS
Brain Behav Immun; 2016 Jul; 55():191-201. PubMed ID: 26518296
[TBL] [Abstract][Full Text] [Related]
20. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
